Journal of Bioethical Inquiry

, Volume 6, Issue 2, pp 181–185 | Cite as

Do Physicians’ Legal Duties to Patients Conflict with Public Health Values? The Case of Antibiotic Overprescription

  • Carl H. ColemanEmail author


Among the many explanations for antibiotic overprescription, some doctors cite the risk of malpractice liability if they deny a patient's request for an antibiotic and the patient's condition worsens. In this paper, I examine the merits of this concern—i.e., whether physicians could, in fact, face malpractice liability for refusing to prescribe an antibiotic when, from a public health perspective, the use of the antibiotic would be considered inappropriate. I conclude that the potential for liability cannot be dismissed entirely, but the risk is remote—even in cases where there is a chance that the antibiotic might have benefited the patient.


Over-prescription Malpractice Anti-biotics 


  1. Ackerman, F. 1991. The significance of a wish. Hastings Ctr. Rep 21: 27–30. doi: 10.2307/3562998.CrossRefGoogle Scholar
  2. Brushwood, D.B. 2003. Maximizing the value of electronic prescription monitoring programs. The Journal of Law, Medicine & Ethics 31: 41–54. doi: 10.1111/j.1748-720X.2003.tb00058.x.CrossRefGoogle Scholar
  3. Canterbury v. Spence, 150 U.S. App. D.C. 263, 464 F.2d 772 (D.C. Cir. 1972).Google Scholar
  4. Coleman, C.H. 2005. Duties to subjects in clinical research. Vanderbilt Law Review 58: 387–449.Google Scholar
  5. Department of Health and Human Services.2005. Part 46: Protection of Human Subjects. Accessed 4 April 2009.
  6. Furrow, B.R. 1997. Managed care organizations and patient injury: Rethinking liability. Georgia Law Review (Athens, Ga.) 31: 419–509.Google Scholar
  7. Gonzales, R., et al. 2001. Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: Background, specific aims, and methods. Annals of Internal Medicine 134: 479–486.PubMedGoogle Scholar
  8. Howard, D. 2007. Patient and physician demand for antibiotics. In Extending the Cure: Policy responses to the growing threat of antibiotic resistance, ed. Laxminarayan Ramanan, and Malani Anup. Washington: RFF Press.Google Scholar
  9. Laxminarayan, R., and Malani, A. (Eds.). 2007. Extending the Cure: Policy responses to the growing threat of antibiotic resistance. Washington: RFF Press.Google Scholar
  10. Meier, B. (2008). Study finds few pain doctors face criminal prosecutions. The New York Times, 20 September, A16.Google Scholar
  11. Peters, P.G. 2000. The quiet demise of deference to custom: Malpractice law at the millennium. Washington and Lee Law Review 57: 163–205.Google Scholar
  12. Pope, T.M. 2007. Medical futility statutes: No safe harbor to unilaterally refuse life-sustaining treatment. Tennessee Law Review 75: 1–80.Google Scholar
  13. Rodwin, M.A. 1995. Strains in the fiduciary metaphor: Divided physician loyalties and obligations in a changing health care system. American Journal of Law & Medicine 21: 241–257.Google Scholar
  14. Selgelid, M.J. 2007. Ethics and drug resistance. Bioethics 21(4): 218–229. doi: 10.1111/j.1467-8519.2006.00542.x.PubMedCrossRefGoogle Scholar
  15. Solomon, D.H., et al. 2001. Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Archives of Internal Medicine 161: 1897–1902. doi: 10.1001/archinte.161.15.1897.PubMedCrossRefGoogle Scholar
  16. Tarasoff v. Regents of the University of California, 17 Cal.3d 425, 551 P.2d 334 (1976).Google Scholar
  17. Ziegler, S.J., and N.P. Lorich Jr. 2003. Pain relief, prescription drugs, and prosecution: A four-state survey of chief prosecutors. The Journal of Law, Medicine & Ethics 31: 75–100. doi: 10.1111/j.1748-720X.2003.tb00060.x.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  1. 1.Center for Health & Pharmaceutical Law & PolicySeton Hall University School of LawNewarkUSA

Personalised recommendations